Companies: 10,795·Total market cap: $144.5T
Abivax S.A.

Abivax S.A.

ABVXNASDAQHealthcare● Active
$101.53
+$0.00(+0.00%)
Market Cap$6.7B
P/E Ratio
52W High$148.83
52W Low$5.69
Overview

Abivax S.A. (ABVX) · Cash Flow

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · ABVX · as of 2026-06-10

Financial statements

Operating CF · CapEx · Free Cash Flow
Breakdown2025-122024-122023-122022-122021-12
Operating Activities
Net Income($0.32B)($0.18B)($0.15B)($0.06B)($0.04B)
Depreciation & Amort.$0.00B$0.00B$0.00B$0.00B$0.00B
Stock-Based Comp.$0.00B$0.02B$0.01B($0.00B)$0.00B
Change in Working Capital$0.00B$0.00B$0.02B($0.00B)($0.00B)
Net Cash from Operations($0.16B)($0.15B)($0.10B)($0.05B)($0.05B)
Investing Activities
Capital Expenditure($0.00B)($0.00B)($0.00B)($0.00B)($0.00B)
Purchases of Investments($0.01B)$0.00B($0.01B)($0.00B)($0.00B)
Sales of Investments$0.00B$0.00B$0.00B$0.00B($0.00B)
Net Cash from Investing($0.01B)$0.02B($0.01B)($0.01B)($0.00B)
Financing Activities
Common Stock Repurchased$0.00B$0.00B$0.00B$0.00B$0.00B
Dividends Paid$0.00B$0.00B$0.00B$0.00B$0.00B
Debt Issued / Repaid($0.06B)$0.04B$0.02B($0.01B)$0.02B
Net Cash from Financing$0.53B$0.03B$0.34B$0.03B$0.08B
Free Cash Flow
Free Cash Flow($0.16B)($0.15B)($0.10B)($0.05B)($0.05B)
FCF Margin %(computed)

Data source: Financial Modeling Prep · Last updated: 2026-06-10 · EUR · B

Explore more Abivax S.A. data

About Abivax S.A. (ABVX) Cash Flow Statement

Abivax S.A. generated operating cash flow of ($0.16B) and free cash flow of ($0.16B) for 2025 — a FCF margin of —. Capital expenditure was ($0.00B).

Frequently asked questions

ABVX · 4 questions

Abivax S.A. generated free cash flow of ($0.16B) for 2025, down 0.7% year-over-year.

ABVX free cash flowFCF margincash flow yield

· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10